Today: 4 December 2025
Subscribe
Browse Category

Financial Outlook News 4 October 2025 - 26 November 2025

Glencore (LON: GLEN) share price today, 11 Nov 2025: gains as copper steadies; Q3 output, $1bn buyback & UK legal case in focus

Glencore Share Price Today, 20 November 2025: GLEN Slips to ~351p as Smelter Cuts, Offtake Deals and Transition Headlines Shape Outlook

Glencore plc (LON: GLEN), the FTSE 100‑listed commodities and mining giant, is trading slightly lower in London on Thursday, 20 November 2025, even as fresh news breaks on South African smelter closures, copper offtake financing in South Africa and mine‑land
20 November 2025
 ·  ·  ·  ·  · 
Vodafone (LSE: VOD) lifts dividend for the first time in 8 years, launches €500m buyback and targets upper‑end FY26 outlook — stock pops on 11 Nov 2025

Vodafone (LSE: VOD) lifts dividend for the first time in 8 years, launches €500m buyback and targets upper‑end FY26 outlook — stock pops on 11 Nov 2025

Date: 11 November 2025 Vodafone Group plc (LSE: VOD) surged in London today after unveiling half‑year results that showed improving momentum across key markets, a new progressive dividend policy (implying a 2.5% rise in the full‑year payout), and the start
11 November 2025
 ·  ·  ·  · 
Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

What’s new today Earnings: Stagwell Inc. (NASDAQ: STGW) reported third‑quarter revenue of $743 million, GAAP EPS of $0.09, and adjusted EPS of $0.24. Management highlighted double‑digit “ex‑advocacy” momentum, with net revenue ex‑advocacy up 10% to $578 million, and adjusted EBITDA
6 November 2025
 ·  ·  ·  ·  ·  · 
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

BMY Stock Bounces After Earnings – Recent Performance Bristol Myers Squibb’s stock has been under pressure for most of 2025, but the Q3 report provided a much-needed boost. Heading into earnings, BMY shares were near 52-week lows, reflecting investor skittishness
30 October 2025
 ·  ·  ·  · 
1 2 3
Go toTop